To repeal the amendments made to the Controlled Substances Act by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016.
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Oct 19, 2017)
This bill repeals two sections of the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 and the amendments made by such sections to the Controlled Substances Act. The repealed sections modified registration and enforcement authorities of the Drug Enforcement Administration with respect to manufacturers, distributors, and dispensers of controlled substances.
What just happenedNov 1, 2017
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Who’s behind it
- Introduced in HouseOct 19, 2017
- Nov 1, 2017Committee
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Crime and Federal Government Surveillance Subcommittee - Oct 20, 2017Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Oct 19, 2017IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Judiciary Committee - Oct 19, 2017IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Oct 19, 2017IntroReferralIntro-H
Introduced in House
- Oct 19, 2017IntroReferral1000
Introduced in House